BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/23/2020 5:00:01 AM | Browse: 872 | Download: 2050
 |
Received |
|
2020-02-27 11:26 |
 |
Peer-Review Started |
|
2020-02-27 11:26 |
 |
First Decision by Editorial Office Director |
|
2020-04-22 22:58 |
 |
Return for Revision |
|
2020-04-25 14:13 |
 |
Revised |
|
2020-05-20 06:18 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2020-06-01 09:40 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2020-06-02 18:22 |
 |
Articles in Press |
|
2020-06-02 18:22 |
 |
Edit the Manuscript by Language Editor |
|
2020-06-11 06:25 |
 |
Typeset the Manuscript |
|
2020-07-07 07:19 |
 |
Publish the Manuscript Online |
|
2020-07-23 05:00 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Takayoshi Suga, Ken Sato, Tatsuya Ohyama, Sho Matsui, Takeshi Kobayashi, Hiroki Tojima, Norio Horiguchi, Yuichi Yamazaki, Satoru Kakizaki, Ayaka Nishikido, Takashi Okamura, Masanobu Yamada, Tadahiro Kitamura and Toshio Uraoka |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ken Sato, MD, PhD, Associate Professor, Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi 371-8511, Gunma, Japan. satoken@gunma-u.ac.jp |
| Key Words |
Selective sodium glucose cotransporter 2; Nonalcoholic fatty liver disease; Sirtuin 1; Peroxisome proliferator-activated receptor γ coactivator 1α; Peroxisome proliferator-activated receptor α; Fibroblast growth factor-21 |
| Core Tip |
The selective sodium glucose cotransporter 2 inhibitor ipragliflozin significantly ameliorated hepatic lipid accumulation in genetically obese (ob/ob) mice and increased both the mRNA and protein expression levels of sirtuin 1 (SIRT1), a NAD+-dependent protein deacetylase with numerous substrates, in the liver. Ipragliflozin also significantly increased the hepatic mRNA levels of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α), peroxisome proliferator-activated receptor α (PPARα), and fibroblast growth factor-21 (FGF21). The liver steatosis-attenuating effects of ipragliflozin in ob/ob mice may have been mediated partly by hepatic SIRT1 signaling, possibly through the PGC-1α/PPARα-FGF21 pathway. |
| Publish Date |
2020-07-23 05:00 |
| Citation |
Suga T, Sato K, Ohyama T, Matsui S, Kobayashi T, Tojima H, Horiguchi N, Yamazaki Y, Kakizaki S, Nishikido A, Okamura T, Yamada M, Kitamura T, Uraoka T. Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling. World J Hepatol 2020; 12(7): 350-362
|
| URL |
https://www.wjgnet.com/1948-5182/full/v12/i7/350.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v12.i7.350 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.